Innovative Imaging Infraredx's Dualpro IVUS+NIRS catheter and Makoto Intravascular Imaging System offer advanced capabilities for cardiovascular diagnostics, providing a compelling solution for hospitals and clinics seeking superior plaque characterization and risk assessment tools.

Market Expansion Recent launches in Japan and the US demonstrate Infraredx’s active strategy to expand its footprint in major cardiovascular markets, presenting opportunities to partner with or supply to hospital networks and cardiology centers looking to adopt cutting-edge imaging technology.

Strategic Collaborations Partnerships like the one with B. Braun Interventional Systems highlight potential sales channels through OEM and device integration opportunities in interventional procedures and catheter-based therapies, increasing market reach.

Regulatory Milestones FDA clearance of the Makoto system underscores the company's commitment to compliance and innovation, a key selling point for hospital procurements requiring validated and approved medical devices.

Financial Potential With a revenue range of $10M to $25M and a funding amount of $25M, Infraredx has growth capacity, making it an attractive partner for healthcare providers investing in novel cardiovascular diagnostic solutions, especially within the large and competitive interventional cardiology market.